Benzinga

Benzinga

Comments

Ayala Pharmaceuticals Attività di insider trading

ADXSOTCEM
Logo offerto da Benzinga Data
Commercio con il pubblico
Commercio con il pubblico
In chiusura: Dec 31, 4:00 PM EST
$0.0510
-122879.95-100.00%
Post-mercato: Nov 10, 8:43 AM EST
PanoramicaNotizieUtiliValutazioni degli analisti

Insider trading

Vendite allo scoperto

Attività di insider trading

Tieni traccia delle ultime attività di insider trading Ayala Pharmaceuticals. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Ayala Pharmaceuticals.

Cos'è l'attività interna?

L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.

Cosa stanno facendo gli Ayala Pharmaceuticals Inc addetti ai lavori?

Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.

Notevoli acquisti e vendite recenti di insider

Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.

Statistiche sulla proprietà per Ayala Pharmaceuticals Inc

Numero di azioni emesse
42.594M
Percentuale posseduta dagli investitori istituzionali
0.02%
Oct 31, 2023Israel Biotech Fund I LPIsrael Biotech Fund II LPIsrael Biotech Fund GP Partners LPIsrael Biotech Fund GP Partners II LPIBF Management Ltd10% OWNER1.32M$0.00$0.00BUY∞1.09MOct 18View
Mar 16, 2020Roni Appel—-3.00K$0.57-$1.70KSELL-22.26%10.48KMar 11 - Mar 13View
Apr 11, 2019Roni AppelDIRECTOR3.00K$3.80$11.39KBUY28.64%13.48KApr 10View
Nov 07, 2018Robert PetitCHIEF SCIENTIFIC OFFICER-3.96K$0.58-$2.30KSELL-1.69%231.21KNov 05View
Nov 05, 2018Robert PetitCHIEF SCIENTIFIC OFFICER-8.49K$0.56-$4.75KSELL-3.48%235.17KNov 02View
Sep 13, 2018Roni AppelDIRECTOR33.33K$1.20$40.00KBUY26.92%157.14KSep 11View
Apr 03, 2018Robert PetitCHIEF SCIENTIFIC OFFICER-1.08K$1.66-$1.68KSELL-0.48%223.50KMar 29 - Apr 02View
Feb 02, 2018Anthony LombardoINTERIM CEO-32.00$2.93-$93.76SELL-0.03%92.90KFeb 02View
Jan 03, 2018Sara BonsteinCHIEF FINANCIAL OFFICER-4.75K$3.01-$15.27KSELL-2.08%224.01KDec 29 - Jan 03View
Nov 06, 2017Robert PetitCHIEF SCIENTIFIC OFFICER-3.72K$3.30-$12.29KSELL-1.66%220.92KNov 06View
Nov 06, 2017Sara BonsteinCHIEF FINANCIAL OFFICER-3.86K$3.30-$12.74KSELL-1.67%227.91KNov 06View
Nov 02, 2017Anthony LombardoINTERIM CEO-24.00$3.19-$76.56SELL-0.03%92.94KNov 02View
Nov 02, 2017Robert PetitCHIEF SCIENTIFIC OFFICER-12.19K$3.29-$38.80KSELL-5.15%224.64KOct 31 - Nov 02View
Nov 02, 2017Sara BonsteinCHIEF FINANCIAL OFFICER-12.36K$3.29-$39.33KSELL-5.06%231.77KOct 31 - Nov 02View
Oct 12, 2017ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER-600.00K$4.30-$2.58MSELL-12.77%4.10MOct 11View
Sep 26, 2017ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER-1.24M$4.42-$5.47MSELL-20.87%4.70MSep 22 - Sep 26View
Apr 03, 2017Petit RobertCHIEF SCIENTIFIC OFFICER-2.23K$8.21-$18.43KSELL-1.83%119.60KMar 31View
Jan 03, 2017Sara BonsteinCHIEF FINANCIAL OFFICER44.72K$7.26-$38.98KGRANT54.56%126.68KDec 30View
Dec 21, 2016Thomas MckearnDIRECTOR-12.32K$8.08-$99.51KSELL-15.00%69.80KDec 20View
Nov 02, 2016Petit RobertCHIEF SCIENTIFIC OFFICER-2.63K$8.20-$21.95KSELL-2.13%120.74KOct 31 - Nov 02View
Nov 02, 2016Daniel O'ConnorCHIEF EXECUTIVE OFFICER-8.00K$8.20-$66.65KSELL-2.64%294.66KOct 31 - Nov 02View
Oct 26, 2016Gregory MayesCHIEF BUSINESS OFFICER-19.16K$8.23-$157.70KSELL-15.67%103.09KOct 25View
Aug 10, 2016Richard BermanDIRECTOR-33.76K$15.42-$520.75KSELL-39.99%50.67KAug 08 - Aug 09View
Aug 10, 2016David SidranskyDIRECTOR-22.81K$15.01-$342.35KSELL-22.11%80.36KAug 08 - Aug 09View
May 13, 2016Thomas MckearnDIRECTOR-4.10K$7.45-$30.55KSELL-4.76%82.12KMay 13View
May 02, 2016Petit RobertCHIEF SCIENTIFIC OFFICER-2.61K$7.63-$19.59KSELL-2.05%125.12KApr 29 - May 02View
May 02, 2016Daniel O'ConnorCHIEF EXECUTIVE OFFICER-7.62K$7.63-$57.11KSELL-2.42%307.82KApr 29 - May 02View
Apr 01, 2016Petit RobertCHIEF SCIENTIFIC OFFICER-3.18K$9.08-$29.06KSELL-2.43%127.73KMar 31View
Mar 18, 2016Thomas MckearnDIRECTOR-14.00K$8.25-$115.50KSELL-13.97%86.22KMar 16View
Feb 25, 2016Sara BonsteinCHIEF FINANCIAL OFFICER-15.04K$5.58-$83.91KSELL-15.83%79.98KFeb 24View
Feb 01, 2016Petit RobertCHIEF SCIENTIFIC OFFICER-2.93K$6.85-$20.15KSELL-2.19%130.56KJan 29View
Feb 01, 2016Daniel O'ConnorCHIEF EXECUTIVE OFFICER-8.21K$6.85-$56.49KSELL-2.55%313.39KJan 29View
Dec 21, 2015Richard BermanDIRECTOR14.33K$12.39$177.57Ks20.45%84.43KDec 17View
Nov 03, 2015Petit RobertCHIEF SCIENTIFIC OFFICER-2.77K$11.66-$34.04KSELL-2.04%133.10KOct 30View
Nov 03, 2015Daniel O'ConnorCHIEF EXECUTIVE OFFICER-8.03K$11.65-$98.82KSELL-2.36%331.73KOct 30View
Oct 27, 2015Gregory MayesCHIEF OPERATING OFFICER-19.23K$11.63-$223.66KSELL-13.83%119.82KOct 26View
Oct 22, 2015David J MauroCHIEF MEDICAL OFFICER-24.59K$10.08-$247.83KSELL-12.90%165.93KOct 20View
Aug 24, 2015ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER300.00K$14.15$4.25MBUY5.32%5.94MAug 20 - Aug 24View
Aug 04, 2015Petit RobertCHIEF SCIENTIFIC OFFICER-2.85K$16.07-$43.81KSELL-2.06%135.59KJul 31View
Aug 04, 2015Daniel O'ConnorCHIEF EXECUTIVE OFFICER-8.13K$16.07-$125.20KSELL-2.34%338.86KJul 31View
May 04, 2015ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER500.00K$19.00$9.50MBUY9.73%5.64MApr 30View
Feb 20, 2015ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER684.76K$7.50$5.14MBUY15.37%5.14MFeb 18View
May 09, 2014Richard BermanDIRECTOR-14.53K$2.63-$38.25KSELL-100.00%0.00May 09View
Apr 02, 2014Daniel O'ConnorCHIEF EXECUTIVE OFFICER3.33K$3.00$10.00KBUY1.08%311.02KMar 31View
Oct 29, 2013James P PattonDIRECTOR25.00K$4.00$100.00KBUY39.74%87.91KOct 24View
Oct 29, 2013Roni AppelDIRECTOR12.50K$4.00$50.00KBUY28.08%57.02KOct 24View
Oct 28, 2013Mark J RosenblumCHIEF FINANCIAL OFFICER12.00K$4.00$48.00KBUY110.07%22.90KOct 24View
Oct 28, 2013Robert PetitCHIEF SCIENTIFIC OFFICER12.80K$4.00$51.20KBUY282.00%17.34KOct 24View
Oct 28, 2013Daniel OConnorCHIEF EXECUTIVE OFFICER13.50K$4.00$54.00KBUY28.27%61.26KOct 24View
Jul 10, 2013Richard J BermanDIRECTOR1.14M$0.04-$24.76KGRANT168.05%1.82MNov 20 - Jun 12View
Feb 19, 2010Richard BermanDIRECTOR-760.62K$0.16-$121.70KSELL-100.00%0.00Feb 12View
Oct 30, 2007John F RothmanVP CLINICAL DEVELOPMENT61.04K$0.18$10.99KBUY28.43%275.77KOct 25View
Oct 30, 2007Fredrick D CobbVICE PRESIDENT FINANCE40.70K$0.18$7.33KBUY81.98%90.34KOct 25View
Oct 26, 2007Thomas A MooreCHAIRMAN / CEO2.67M$0.15$400.00KBUY∞2.67MOct 23View
Mar 01, 2007John RothmanVP CLINICAL DEVELOPMENT134.73K$0.16$21.56KBUY168.41%214.73KFeb 23View
Mar 01, 2007Fred D. CobbVICE PRESIDENT FINANCE49.64K$0.16$7.94KBUY∞49.64KFeb 23View
Jan 10, 2007Roni AppelDIRECTOR1.59M$0.20$311.60KBUY66.88%3.98MJan 25 - Jan 03View

FAQ

Q

L'insider trading è legale?

A
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Q

Quali sono alcuni esempi di manipolazione del mercato?

A
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.

Sfoglia insider trading su tutte le azioni.

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved